Log in to save to my catalogue

Application of HER2 peptide vaccines in patients with breast cancer: a systematic review and meta-an...

Application of HER2 peptide vaccines in patients with breast cancer: a systematic review and meta-an...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_4925c470c87649a08dc83cc937402e74

Application of HER2 peptide vaccines in patients with breast cancer: a systematic review and meta-analysis

About this item

Full title

Application of HER2 peptide vaccines in patients with breast cancer: a systematic review and meta-analysis

Publisher

London: BioMed Central Ltd

Journal title

Cancer Cell International, 2021-09, Vol.21 (1), p.1-489, Article 489

Language

English

Formats

Publication information

Publisher

London: BioMed Central Ltd

More information

Scope and Contents

Contents

Background The E75 and GP2 vaccines are the few therapeutic vaccines targeting HER2 currently under clinical research for patients with breast cancer. Methods Databases, including the Cochrane Library, PubMed, Medline, Embase, and Web of Science, were used to retrieve clinical studies on E75 and GP2 vaccines. Retrieval time was from the beginning o...

Alternative Titles

Full title

Application of HER2 peptide vaccines in patients with breast cancer: a systematic review and meta-analysis

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_4925c470c87649a08dc83cc937402e74

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_4925c470c87649a08dc83cc937402e74

Other Identifiers

ISSN

1475-2867

E-ISSN

1475-2867

DOI

10.1186/s12935-021-02187-1

How to access this item